Table 11 Agreement between PET/CT and BMB in mixed cellularity cases
From: PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma
| Â | Â | BMB | Â | Total | |
|---|---|---|---|---|---|
Negative | Positive | Â | |||
PET/CT | Negative | Count | 19 | 0 | 19 |
% of total | 73.1% | 0.0% | 73.1% | ||
Positive | Count | 4 | 3 | 7 | |
% of total | 15.4% | 11.5% | 26.9% | ||
Total | Â | Count | 23 | 3 | 26 |
% of total | 88.5% | 11.5% | 100.0% | ||